LEVALLOIS-PERRET, France, Nov 17, 2025 – Linxens and Presto Engineering are developing a new platform for connected biosensors for medical applications. The initiative will be showcased at MEDICA 2025.
A Biosensor Platform Concept for the Next Era of Diagnostics
The collaboration aims to build a platform that combines sensing, connectivity and semiconductor functions in a single disposable device. It pairs Presto’s ASIC (application-specific integrated circuit) design capabilities with Linxens’ expertise in flexible biosensors, electrodes, antennas and high-volume manufacturing. The effort aims to develop a biosensor platform for medical and diagnostic uses.
The platform is designed around four principles:
- Affordability and disposability for cost-sensitive healthcare contexts,
- Compact and lightweight construction enhanced comfort and usability,
- Digital connectivity for standardized results
- Industrial scalability supported by Linxens’ high-volume manufacturing expertise.
- Design flexibility to support multiple formats and use cases
Broad Potential Across Healthcare and Beyond
The platform uses a modular design that supports contamination-free point-of-care testing, wearable monitoring and analysis for food safety and environmental control. Its architecture allows updates for new diagnostic needs while maintaining costing. Linxens Healthcare and Presto Engineering support efficient workflows, portable devices for field or low-resource settings and discreet sensors that help with patient adherence.. In industrial and environmental settings, the platform enables on-site testing for pathogens or contaminants and provides fast digital promptly.
“This collaboration is about more than just a new concept – it’s about laying the foundation for a platform that makes connected diagnostics practical, affordable, and scalable for real-world healthcare,” said Pierre O. Beal, healthcare product strategy manager at Linxens Healthcare. “We see this as a basis for future innovation in testing and monitoring, empowering providers and patients with reliable digital data at the point of need.
“From a technology standpoint, the breakthrough lies in embedding intelligence directly into the biosensor platform,” explained Frédéric Valentin, SVP sales & marketing at Presto Engineering. “Our next-generation silicon platform brings secure connectivity and advanced signal processing into a compact, disposable format. When combined with Linxens’ flexible electronics and industrial-scale manufacturing, it creates a versatile architecture that can be tailored to applications ranging from infectious disease testing to wearable patient monitoring.”
Source: Presto Engineering
About Linxens
Linxens supplies the electronics sector with microconnectors, module packaging, antennas and inlays, and secure ID components used in government, payment, telecom, healthcare, mobility, smart-access and IoT applications. The company traces its roots to 1983 and is based in Levallois-Perret, France. Linxens also operates R&D centers and factories worldwide and employs more than 3,000 people. The Linxens Healthcare brand develops biosensors, electronic skin patches, wearable devices and track-and-trace components built on the Group’s experience in microconnectors and flexible electronics. These products support monitoring, diagnostics and patient-care applications across the healthcare sector.
About Presto Engineering
Presto Engineering designs and produces integrated circuits for medical, automotive, industrial and communications devices. The company, founded in 2006, is headquartered in Meyreuil, France, with additional sites in the United States, Denmark, the United Kingdom and Asia. Presto develops custom ASICs for medical wearables and diagnostics and supports low-power operation, miniaturization and long-term reliability. The company holds ISO 13485 certification for medical-device development and manages the ASIC workflow, including design, test development, qualification, packaging and volume production. Presto also offers silicon platforms that provide integrated-circuit baselines for new medical designs. The company employs more than 150 people, operates multiple engineering labs in Europe and manages a global supply chain capable of producing over 50 million units annually.